Traditional Chinese Medicine Containing Arsenic Treated MDS Patients Effectively through Regulating Aberrant Hypomethylation
Aberrant hypermethylation and hypomethylation both play important roles in myelodysplastic syndrome (MDS). Hypomethylating agents targeting hypermethylation have been employed for the MDS treatment, but the treatment effect is limited. Novel drugs for DNA hypomethylation-targeted therapy may be need...
Main Authors: | Qing-bing Zhou, Qian-zhe Zhu, Hong-zhi Wang, De-xiu Wang, Zheng-tang Liu, Yong-gang Xu, Xiao-mei Hu, Rou Ma, Feng-qin Xu |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Evidence-Based Complementary and Alternative Medicine |
Online Access: | http://dx.doi.org/10.1155/2020/7469809 |
Similar Items
-
Beyond the Edge of Hypomethylating Agents: Novel Combination Strategies for Older Adults with Advanced MDS and AML
by: Anne Sophie Kubasch, et al.
Published: (2018-05-01) -
Karyotype and DNA-Methylation Responses in Myelodysplastic Syndromes following Treatment with Traditional Chinese Formula Containing Arsenic
by: Sun Shuzhen, et al.
Published: (2012-01-01) -
Arsenic Disulfide Promoted Hypomethylation by Increasing DNA Methyltransferases Expression in Myelodysplastic Syndrome
by: Zhou QB, et al.
Published: (2020-04-01) -
Aberrant promoter hypomethylation in CLL: does it matter for disease development?
by: Garland Michael Upchurch, et al.
Published: (2016-08-01) -
Aberrant Promoter Hypomethylation of Sortilin 1: A Moyamoya Disease Biomarker
by: Hye Youn Sung, et al.
Published: (2018-09-01)